Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session



  • HTG Molecular Diagnostics, Inc. HTGM shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
  • Harpoon Therapeutics, Inc. HARP rose 97.3% to $2.27 after the company announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
  • Tonix Pharmaceuticals Holding Corp. TNXP gained 85% to $0.69 after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2 monoclonal antibodies from Curia Global.
  • Aptevo Therapeutics Inc. APVO shares climbed 65.6% to $5.68 after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
  • Faraday Future Intelligent Electric Inc. FFIE rose 56.2% to $0.4612 after gaining over 11% on Friday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company, effective immediately.
  • China Jo-Jo Drugstores, Inc. CJJD jumped 39.9% to $4.63 after jumping 53% on Friday.
  • Dragonfly Energy Holdings Corp. DFLI surged 34.5% to $14.80.
  • Virax Biolabs Group Limited VRAX jumped 28.7% to $1.30.
  • United Insurance Holdings Corp. UIHC gained 28.3% to $0.4297. The company, last month, posted downbeat quarterly results.
  • Reborn Coffee, Inc. REBN rose 28.3% to $1.3602 after jumping around 22% on Friday. Reborn Coffee recently signed a Letter of Intent to acquire a specialty coffee shop and a roasting research and development facility in Daejeon, South Korea as a part of its global expansion plan.
  • Coupa Software Incorporated COUP shares gained 26.6% to $78.63 after the company announced it will be acquired by Thoma Bravo for $8 billion.
  • BIMI International Medical, Inc. BIMI gained 25% to $2.60. BIMI recently announced a 1-for-10 reverse stock split.
  • Weber Inc. WEBR jumped 24.9% to $8.12 after the company entered an agreement to be taken private by BDT Capital Partners for $8.05 per share.
  • Avalon GloboCare Corp. ALBT gained 24.4% to $0.3980. Avalon GloboCare announced a new proposed board composition in preparation for acquisition of Laboratory Services MSO, LLC.
  • Kingstone Companies, Inc. KINS jumped 22% to $1.33.
  • Bruush Oral Care Inc. BRSH shares rose 21.6% to $0.59. Bruush Oral Care reported closing of $3.0 million private placement.
  • EZFill Holdings Inc. EZFL gained 19% to $0.46. EzFill Holdings, last month, posted a Q3 loss of $0.15 per share.
  • Chemomab Therapeutics Ltd. CMMB jumped 15% to $2.7601.
  • Horizon Therapeutics Public Limited Company HZNP rose 14.6% to $111.48 after Amgen announced it will acquire the company for $116.50 per share in cash.
  • Studio City International Holdings Limited MSC gained 14% to $5.33.
  • Aerovate Therapeutics, Inc. AVTE jumped 13.7% to $28.20.
  • 111, Inc. YI gained 13% to $3.73. 111 recently posted Q3 adjusted loss of $0.10 per share.
  • Oriental Culture Holding LTD OCG gained 12.9% to $0.8355.
  • China SXT Pharmaceuticals, Inc. SXTC rose 11.5% to $0.6471 after gaining over 20% on Friday.
  • Connexa Sports Technologies Inc. CNXA gained 10.8% to $0.18.
  • Cogent Biosciences, Inc. COGT jumped 10.7% to $12.29 after the company announced updated clinical data from ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis.
  • Pitney Bowes Inc. PBI jumped 9.4% to $4.19. Hestia Capital confirmed intent to overhaul Pitney Bowes' board of directors following 10+ years of significant value destruction under Chair Michael Roth and CEO Marc Lautenbach.
  • Frontline Ltd. FRO gained 8.8% to $13.95. Frontline, last week, issued a Form424B3 filing highlighting a proposal to increase the company’s authorized share capital from $500 million to $600 million.
  • HashiCorp, Inc. HCP jumped 7.6% to $31.87. HashiCorp recently reported better-than-expected Q3 sales results.


  • Affimed N.V.. AFMD fell 39.2% to $1.24 after the company announced topline data from its Phase 2 REDIRECT study of AFM13 monotherapy in patients with advanced-stage relapsed/refractory peripheral T cell lymphoma.
  • Ambrx Biopharma Inc. AMAM fell 38.3% to $2.7991. Ambrx Biopharma shares jumped over 1,007% on Friday after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
  • Adicet Bio, Inc. ACET shares fell 37.2% to $10.85 after the company announced safety and efficacy data from its ongoing Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell NHL.
  • Rockley Photonics Holdings Limited RKLY dropped 34.8% to $0.2601.
  • TeraWulf Inc. WULF dipped 31% to $0.8388. TeraWulf increased expected Q1 2023 self-mining hash rate at no additional cost and announced repayment of certain debt.
  • SHF Holdings, Inc. SHFS fell 26.6% to $2.43.
  • Curis, Inc. CRIS fell 25.1% to $0.5744 after the company announced additional clinical data from TakeAim Leukemia study of emavusertib in monotherapy R/R AML and hrMDS.
  • Fangdd Network Group Ltd. DUO dropped 23.2% to $0.9369. Xi Zeng recently disclosed a 6.5% active stake in Fangdd Network Group Ltd.
  • Appreciate Holdings, Inc. SFR declined 20.3% to $2.20.
  • Inotiv, Inc. NOTV fell 20.2% to $4.5350 after the company issued FY22 sales guidance below estimates.
  • Baudax Bio, Inc BXRX shares fell 16.8% to $4.3261. Baudax Bio shares gained around 28% on Friday after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • HUYA Inc. HUYA fell 16.3% to $2.9050. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
  • TAL Education Group TAL dipped 16% to $5.55.
  • Baozun Inc. BZUN fell 15.3% to $4.91. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
  • DouYu International Holdings Limited DOYU dropped 14.9% to $1.2850. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
  • Fate Therapeutics, Inc. FATE fell 14.6% to $16.10. GT Biopharma and Fate Therapeutics presented preclinical data highlighting novel dual antigen targeting approach for the treatment of AML at ASH 2022.
  • Dada Nexus Limited DADA dropped 14% to $6.34. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
  • UpHealth, Inc. UPH fell 13.5% to $2.1180.
  • Lufax Holding Ltd LU declined 13.4% to $1.9909. Shares of Chinese companies traded lower amid a pullback after gaining last week following the easing of zero-Covid restrictions.
  • Hello Group Inc. MOMO dropped 13.2% to $7.75.
  • Hillstream BioPharma, Inc. HILS fell 11.5% to $0.5389 after climbing 43% on Friday. Hillstream BioPharma recently company announced the development of proprietary targeted biologics, Knob Quatrabodies against PD-1.
  • Meta Materials Inc. MMAT fell 11.3% to $1.26 after dipping 22% on Friday. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
  • Ensysce Biosciences, Inc. ENSC shares fell 10.8% to $1.07 after jumping 21% on Friday. Ensysce Biosciences recently announced pricing of a $4.1 million public offering.
  • Panbela Therapeutics, Inc. PBLA fell 7.2% to $0.0917.

Also check this out Bitcoin Drops But Remains Above This Key Level; Chiliz, Dogecoin Among Top Losers.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!